3,2-Benzoxazepine derivatives
    5.
    发明授权
    3,2-Benzoxazepine derivatives 失效
    3,2 - 苯并氧氮杂衍生物

    公开(公告)号:US4041048A

    公开(公告)日:1977-08-09

    申请号:US523790

    申请日:1974-11-14

    CPC分类号: C07D267/14 C07D267/04

    摘要: 3,2-Benzoxazepines of the formula ##STR1## and their preparation. In formula (I), R respesents hydrogen or lower alkyl; R.sup.1 represents hydrogen, lower alkyl, lower alkenyl, hydroxy-lower alkyl, carbamyloxy-lower alkyl, acyl, amidino, carbamyl, mono- or di-substituted carbamyl; R.sup.2 may be in position 7 or 8 of the benzoxazepine ring and represents hydrogen, nitro, amino, acetamino or halo. The compounds are prepared by reacting 1,2,4,5-tetrahydro-3,2-benzoxazepine with a reactant which reacts with a secondary amino group to give substitution in the 2-position. The compounds have anti-inflammatory and central nervous system activity.

    摘要翻译: 式(I)的“3-苯并氧氮杂”< IMAGE>及其制备。 在式(I)中,R表示氢或低级烷基; R 1表示氢,低级烷基,低级烯基,羟基 - 低级烷基,氨基甲酰氧基 - 低级烷基,酰基,脒基,氨基甲酰基,单或二取代的氨基甲酰基; R2可以位于苯并氧氮杂环的7或8位,代表氢,硝基,氨基,乙酰氨基或卤素。 该化合物通过使1,2,4,5-四氢-3,3-苯并氧氮杂与与仲氨基反应以在2-位取代的反应物进行制备。 该化合物具有抗炎和中枢神经系统活性。